News Channels

17 Jul 2018 SOM Biotech Announces Initiation of Phase 2a Clinical Trial of SOM3355 in Huntington's Disease Patients
17 Jul 2018 Eisai Inc. Announces Positive Topline Results from CAMELLIA-TIMI 61, a Large-Scale Cardiovascular Outcome Trial for the Anti-Obesity Agent BELVIQ®
17 Jul 2018 Phase 3 CREDENCE Renal Outcomes Trial of INVOKANA® (canagliflozin) is Being Stopped Early for Positive Efficacy Findings
17 Jul 2018 Voyager Therapeutics Receives FDA Guidance on Development Path for VY-AADC for Parkinson’s Disease and Provides Clinical Update
17 Jul 2018 Advanced Proteome Therapeutics Announces Collaboration with Noria Pharmaceuticals
17 Jul 2018 Cellectar Reports 94% Reduction in Overall Tumor Volume in Waldenstrom Macroglobulinemia Patient in Phase 2 CLR 131 Clinical Study
17 Jul 2018 Eureka Therapeutics Announces that Boehringer Ingelheim is Exercising an Option to License Novel TCR Mimic (TCRm) Antibodies
17 Jul 2018 AbbVie Announces HUMIRA® (adalimumab) Patent License with Mylan
17 Jul 2018 Concentric Analgesics Initiates Phase 2 Clinical Study of CA-008 for the Treatment of Post-Surgical Pain
17 Jul 2018 Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy
17 Jul 2018 Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
17 Jul 2018 Phase III CAPSTONE-2 Study Showed That Baloxavir Marboxil Reduced Symptoms in People at High Risk of Complications From the Flu
17 Jul 2018 MaxCyte Receives US FDA Investigational New Drug Clearance for First Clinical Program
17 Jul 2018 Neurotrope Announces the Initiation of Enrollment of its Confirmatory Phase 2 Trial in Alzheimer's Disease
16 Jul 2018 ANP initiates ATL1102 Phase II clinical trial in Duchenne Muscular Dystroph
15 Jul 2018 U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
15 Jul 2018 U.S. Food and Drug Administration Approves SIGA Technologies’ TPOXX® (tecovirimat) for the Treatment of Smallpox
15 Jul 2018 MolMed signs a new, three-year agreement for the development and supply of lentiviral vectors
13 Jul 2018 4D Molecular Therapeutics and MedImmune Collaborate to Design, Develop and Commercialize AAV Gene Therapy for Chronic Lung Disease
13 Jul 2018 Advaxis Announces FDA Lifts Clinical Hold on Phase 1/2 Combination Study of Axalimogene Filolisbac with Durvalumab

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up